KLK1 and endothelial dysfunction: Intravenous administration of exogenous KLK1 can reduce the inflammatory infiltration of the rat prostate and inhibit chronic inflammatory damage, including hypoxia, oxidative stress, angiogenesis, and fibrosis via ameliorating endothelial dysfunction.